The 2021 FASEB virtual Catalyst Conference on B Cells in Injury and Regeneration, April 21, 2021

Kento Kawai, Ann M. Stowe, Conor L. Evans, Ruxandra F. Sîrbulescu, Dusan Hanidziar, Kang Mi Lee, Thomas F. Tedder, Mark C. Poznansky

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numbere21744
JournalFASEB Journal
Volume35
Issue number8
DOIs
StatePublished - Aug 2021

Bibliographical note

Funding Information:
M. C. Poznansky is the scientific founder of B‐Genesys. R. F. Sîrbulescu is a member of the scientific advisory board of B‐Genesys. T. F. Tedder is the founder, holds shares in, and receives funding from Cellective BioTherapy Inc

Funding Information:
The work presented by A. M. Stowe was supported by the American Heart Association (14SDG18410020), the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS; NS088555), and the Dana Foundation David Mahoney Neuroimaging Program. The work presented by C. L. Evans was supported by the US Department of Defense/Military Medical Photonics Program (FA9550‐16‐1‐0479). The work presented by R. F. Sîrbulescu was supported by the Massachusetts General Hospital Vaccine and Immunotherapy Center (VIC) Innovation Fund; the Trinity Innovation Fund, Holy Cross Hospital, Ft. Lauderdale, FFL, USA; and The Ward Family Fund for Regenerative Medicine at VIC. The work presented by D. Hanidziar is supported by a Clinical Investigator Award (K08HL141694) from the NIH/National Heart, Lung, and Blood Institute (NHLBI).

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this